MapLight Therapeutics, Inc. (MPLT) — Dilution Risk Analysis
Current Snapshot
MapLight Therapeutics, Inc. (MPLT) has a DilutionWatch score of 55/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 55/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 6, XBRL 1.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-04-17 | 0002021233-26-000006 |
| 4 | 2026-04-17 | 0001728746-26-000006 |
| 4 | 2026-04-17 | 0002021256-26-000006 |
| 4 | 2026-04-17 | 0001789970-26-000006 |
| 4 | 2026-04-17 | 0001709954-26-000006 |
| 4 | 2026-04-17 | 0002021238-26-000006 |
| xbrl | 2025-12-31 | xbrl-3591-xbrl_convertible |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 26 months | Source |
| Three-year share count growth | 9.45% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 55/10) Source
- Cash Runway
- 26 months Source
- Share Count Growth (3-Year)
- 9.45% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.